Hypogonadal Men With Psoriasis Benefit From Long-Term Testosterone Replacement Therapy
Psoriasis is increasingly recognised as a skin disease with far-reaching systemic effects, associated with a high prevalence of comorbid disease such as cardiometabolic dysfunction, shifting the focus from a single organ disease confined to the skin to a systemic inflammatory condition. Chronic and systemic inflammation plays a major role in the development of these diseases, and there are striking similarities between the molecular and inflammatory pathways in psoriasis and atherosclerosis. In a single-centre, cumulative, prospective registry study of 347 hypogonadal men (total testosterone ≤12.1 nmol l(-1) ), fifteen men with psoriasis could be studied. Upon testosterone administration, the skin disease improved considerably. Scores on the Psoriasis Area and Severity Index and Physician Global Assessment for Psoriasis showed significant improvement for the first 24 months. Thereafter, these improvements were sustained. Upon testosterone treatment, C-reactive protein declined significantly. There were significant improvements of obesity and of lipid profiles. Adipose tissue is now regarded as a source of inflammatory factors. These preliminary results deserve to be studied in a specifically designed study to investigate the effects of testosterone on psoriasis and its associated immunopathology.
Keywords: C-reactive protein; erectile function; metabolic syndrome; psoriasis; testosterone.
© 2015 Blackwell Verlag GmbH.
Similar articles
-
Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.Andrology. 2015 Nov;3(6):1094-103. doi: 10.1111/andr.12099. Epub 2015 Oct 7.PMID: 26447645 Clinical Trial.
-
Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS).J Sex Med. 2011 Nov;8(11):3204-13. doi: 10.1111/j.1743-6109.2011.02436.x. Epub 2011 Aug 11.PMID: 21834870 Clinical Trial.
-
Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus – a series of case reports.Aging Male. 2015;18(3):164-8. doi: 10.3109/13685538.2015.1034687. Epub 2015 Jun 15.PMID: 26075537 Clinical Trial.
-
Cardiovascular Health, Erectile Dysfunction, and Testosterone Replacement: Controversies and Correlations.Urology. 2017 Dec;110:1-8. doi: 10.1016/j.urology.2017.07.030. Epub 2017 Jul 31.PMID: 28774772 Review.
-
Testosterone replacement therapy in obese males.Acta Pol Pharm. 2011 Sep-Oct;68(5):623-7.PMID: 21928705 Review.